Kadhim, A.A. et al. 2025. Natalizumab Immunogenicity in Multiple Sclerosis: Evaluating Antibody Development and Clinical Outcomes in an Iraqi Cohort. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 9, 2 (Oct. 2025), 83–89. DOI:https://doi.org/10.54133/ajms.v9i2.2352.